Rosal, Adelfa C.
HRN: 27-58-68 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFUROXIME 500MG (TAB)
08/06/2025
08/06/2025
IV
1.5g
Once
Prior To OR
Checking Initial Appropriateness
08/06/2025
CEFUROXIME 500MG (TAB)
08/06/2025
08/13/2025
PO
500mg
BID
S/P Completion Curettage
Checking Initial Appropriateness